James Ford

James Ford discloses dealings in GSK plc to RNS (LSE). Over a trading history stretching from 9 August 2023 to 13 October 2026, the count stands at 136 filings.

On the open market, the record shows 5 purchases and 10 sales worth €8.1M. The totals do not cover 6 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 121 share grants. In 2026 alone, the filings show 2 purchases and 2 sales.

5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 15 October 2026 came the latest disclosure, a share grant for €14k in GSK plc. The clock since the last published purchase (16 April 2026) now reads 184 days. The median gap between a trade and its publication by RNS (LSE) is 3 days. The regulation allows three business days to notify a trade (UK MAR). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.